194 related articles for article (PubMed ID: 19307469)
1. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension.
Kimura S; Egashira K; Chen L; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Morishita R; Sueishi K; Tominaga R; Sunagawa K
Hypertension; 2009 May; 53(5):877-83. PubMed ID: 19307469
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension.
Chen L; Nakano K; Kimura S; Matoba T; Iwata E; Miyagawa M; Tsujimoto H; Nagaoka K; Kishimoto J; Sunagawa K; Egashira K
Hypertension; 2011 Feb; 57(2):343-50. PubMed ID: 21220711
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
[TBL] [Abstract][Full Text] [Related]
6. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.
Ichimura K; Matoba T; Koga JI; Nakano K; Funamoto D; Tsutsui H; Egashira K
Int Heart J; 2018 Nov; 59(6):1432-1444. PubMed ID: 30369578
[TBL] [Abstract][Full Text] [Related]
8. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
[TBL] [Abstract][Full Text] [Related]
9. Intratracheal Administration of Prostacyclin Analogue-incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension.
Akagi S; Nakamura K; Matsubara H; Kondo M; Miura D; Matoba T; Egashira K; Ito H
J Cardiovasc Pharmacol; 2016 Apr; 67(4):290-8. PubMed ID: 26745002
[TBL] [Abstract][Full Text] [Related]
10. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.
Akagi S; Nakamura K; Miura D; Saito Y; Matsubara H; Ogawa A; Matoba T; Egashira K; Ito H
Int Heart J; 2015 May; 56(3):354-9. PubMed ID: 25902888
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.
Bai Y; Li ZX; Wang HL; Lian GC; Wang Y
Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440
[TBL] [Abstract][Full Text] [Related]
12. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M
Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229
[TBL] [Abstract][Full Text] [Related]
13. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
Li XW; Guo B; Shen YY; Yang JR
Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
[TBL] [Abstract][Full Text] [Related]
14. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
Sun LY; Cai ZY; Pu J; Li J; Shen JY; Yang CD; He B
Inflammation; 2017 Jun; 40(3):806-817. PubMed ID: 28213866
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F
Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
Huang WC; Ke MW; Cheng CC; Chiou SH; Wann SR; Shu CW; Chiou KR; Tseng CJ; Pan HW; Mar GY; Liu CP
PLoS One; 2016; 11(2):e0142476. PubMed ID: 26840075
[TBL] [Abstract][Full Text] [Related]
18. Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
Bi LQ; Zhu R; Kong H; Wu SL; Li N; Zuo XR; Zhou SM; Kou JP; Yu BY; Wang H; Xie WP
Int Immunopharmacol; 2013 May; 16(1):7-16. PubMed ID: 23538027
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.
Huang J; Kaminski PM; Edwards JG; Yeh A; Wolin MS; Frishman WH; Gewitz MH; Mathew R
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1250-9. PubMed ID: 18390833
[TBL] [Abstract][Full Text] [Related]
20. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
Sawada H; Mitani Y; Maruyama J; Jiang BH; Ikeyama Y; Dida FA; Yamamoto H; Imanaka-Yoshida K; Shimpo H; Mizoguchi A; Maruyama K; Komada Y
Chest; 2007 Oct; 132(4):1265-74. PubMed ID: 17934115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
